Macquarie Group LTD Atri Cure, Inc. Transaction History

Macquarie Group LTD

$90.3 Billion
Q3 2024

A detailed history of Macquarie Group LTD transactions in Atri Cure, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 2,384,816 shares of ATRC stock, worth $85.9 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

2,384,816

Previous 1,998,049 19.36%

Holding current value

$85.9 Million

Previous $45.5 Million 46.98%

% of portfolio

0.07%

Previous 0.05%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$20.34 - $29.5 $7.87 Million - $11.4 Million	386,767 Added 19.36%	2,384,816 $66.9 Million
Q2 2024 Aug 09, 2024	BUY	$19.86 - $29.09 $11.6 Million - $17 Million	584,824 Added 41.38%	1,998,049 $45.5 Million
Q1 2024 May 14, 2024	SELL	$28.21 - $37.78 $1.03 Million - $1.38 Million	-36,501 Reduced 2.52%	1,413,225 $43 Million
Q4 2023 Feb 14, 2024	SELL	$32.99 - $43.25 $289,487 - $379,518	-8,775 Reduced 0.6%	1,449,726 $51.7 Million
Q3 2023 Nov 14, 2023	BUY	$41.12 - $57.73 $2.42 Million - $3.4 Million	58,851 Added 4.2%	1,458,501 $63.9 Million
Q2 2023 Aug 14, 2023	SELL	$40.44 - $49.6 $390,326 - $478,739	-9,652 Reduced 0.68%	1,399,650 $69.1 Million
Q1 2023 May 15, 2023	BUY	$35.87 - $47.22 $1.2 Million - $1.57 Million	33,348 Added 2.42%	1,409,302 $58.4 Million
Q4 2022 Feb 21, 2023	BUY	$33.48 - $47.45 $454,926 - $644,750	13,588 Added 1.0%	1,375,954 $61.1 Million
Q3 2022 Nov 14, 2022	BUY	$38.25 - $52.62 $223,188 - $307,037	5,835 Added 0.43%	1,362,366 $53.3 Million
Q2 2022 Aug 15, 2022	BUY	$35.1 - $66.01 $7.01 Million - $13.2 Million	199,788 Added 17.27%	1,356,531 $55.4 Million
Q1 2022 May 16, 2022	BUY	$57.43 - $71.39 $1.44 Million - $1.79 Million	25,122 Added 2.22%	1,156,743 $76 Million
Q4 2021 Feb 11, 2022	BUY	$63.4 - $87.14 $2.4 Million - $3.3 Million	37,911 Added 3.47%	1,131,621 $78.7 Million
Q3 2021 Nov 12, 2021	BUY	$69.28 - $84.46 $4 Million - $4.88 Million	57,777 Added 5.58%	1,093,710 $76.1 Million
Q2 2021 Aug 13, 2021	BUY	$64.13 - $80.18 $17.6 Million - $22 Million	274,381 Added 36.03%	1,035,933 $82.2 Million
Q1 2021 May 14, 2021	BUY	$53.79 - $66.98 $15.1 Million - $18.8 Million	281,075 Added 58.5%	761,552 $49.9 Million
Q4 2020 Feb 16, 2021	BUY	$34.56 - $57.55 $15.2 Million - $25.3 Million	439,279 Added 1066.26%	480,477 $26.7 Million
Q3 2020 Nov 13, 2020	BUY	$38.36 - $46.91 $85,389 - $104,421	2,226 Added 5.71%	41,198 $1.64 Million
Q2 2020 Aug 11, 2020	SELL	$31.78 - $51.19 $57,712 - $92,961	-1,816 Reduced 4.45%	38,972 $1.75 Million
Q1 2020 May 15, 2020	SELL	$24.49 - $43.84 $960,767 - $1.72 Million	-39,231 Reduced 49.03%	40,788 $1.37 Million
Q4 2019 Feb 14, 2020	SELL	$24.06 - $32.51 $118,351 - $159,916	-4,919 Reduced 5.79%	80,019 $2.6 Million
Q3 2019 Nov 14, 2019	BUY	$23.81 - $32.52 $358,816 - $490,076	15,070 Added 21.57%	84,938 $2.12 Million
Q2 2019 Aug 14, 2019	SELL	$26.85 - $30.74 $79,878 - $91,451	-2,975 Reduced 4.08%	69,868 $2.09 Million
Q1 2019 May 15, 2019	BUY	$26.38 - $33.34 $186,163 - $235,280	7,057 Added 10.73%	72,843 $1.95 Million
Q4 2018 Feb 15, 2019	BUY	$26.66 - $34.85 $18,155 - $23,732	681 Added 1.05%	65,786 $2.01 Million
Q3 2018 Nov 15, 2018	SELL	$27.62 - $35.58 $678,319 - $873,809	-24,559 Reduced 27.39%	65,105 $2.28 Million
Q2 2018 Aug 14, 2018	SELL	$19.65 - $30.28 $152,287 - $234,670	-7,750 Reduced 7.96%	89,664 $2.43 Million
Q1 2018 May 11, 2018	SELL	$15.05 - $21.03 $39,762 - $55,561	-2,642 Reduced 2.64%	97,414 $2 Million
Q4 2017 Feb 15, 2018	BUY	$17.69 - $23.44 $315,076 - $417,489	17,811 Added 21.66%	100,056 $1.83 Million
Q3 2017 Nov 08, 2017	BUY	$20.0 - $24.23 $1.64 Million - $1.99 Million	82,245	82,245 $1.84 Million

Others Institutions Holding ATRC

# of Institutions

212

Shares Held

49.7M

Call Options Held

12K

Put Options Held

7.2K

View Full List

About AtriCure, Inc.

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.67B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

More about ATRC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Atri Cure, Inc. Transaction History